Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 26 August 2026
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:In developmentProgramme:HealthTech guidanceExpected publication date: TBC
Hearing aids for adults with hearing lossStatus:In developmentProgramme:HealthTech guidanceExpected publication date: 4 February 2027
Self-directed automated audiometry for the diagnosis of hearing loss in adults (provisional title)Status:In developmentProgramme:HealthTech guidanceExpected publication date: TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [ID6379]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 9 September 2026